Stanford researchers awarded close to $9 million for opioid, pain studies

Five researchers were awarded grants from the National Institutes of Health to study opioid misuse and pain treatment.

Five Stanford researchers were awarded grants from the National Institutes of Health’s Helping to End Addiction Long-Term Initiative. The HEAL grants address the nation’s opioid crisis by funding research into opioid misuse, as well as alternatives to pain treatment.

Laura Simons, PhD, associate professor of anesthesiology, perioperative and pain medicine, was awarded $5.4 million to study biological and behavioral processes in adolescents with high-impact chronic musculoskeletal pain.

Luis de Lecea, PhD, professor of psychiatry and behavioral sciences, and Xiaoke Chen, PhD, associate professor of biology, received $1.64 million to investigate the connection between brain circuits involved in opioid use and sleep regulation.

Raag Airan, MD, PhD, assistant professor of radiology, and Nolan Williams, MD, assistant professor of psychiatry and behavioral sciences, received $1.4 million to study the delivery of ketamine to the brain as a treatment for chronic pain.

Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at

COVID-19 Updates

Stanford Medicine is closely monitoring the outbreak of novel coronavirus (COVID-19). A dedicated page provides the latest information and developments related to the pandemic.

Leading In Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.